辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！_老虎社区_美港股上老虎

辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！

智药局04-16

AI制药再迎重磅融资！近日，美国波士顿AI制药公司Alloy Therapeutics宣布完成4000万美元E轮融资。本轮融资后，公司最新一轮融资估值为10亿美元。本轮参投方包括8VC、JIC Venture Growth Investments、Echo Capital等多个知名机构。值得注意的是，Peter Thiel旗下的Thiel Capital、Founders Fund，以及...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2627291839?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-16 18:03","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2627291839","market":"fut","top_or_hot":-1,"title":"辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！","media":"智药局","content":"<div>\n<p>AI制药再迎重磅融资！近日，美国波士顿AI制药公司Alloy Therapeutics宣布完成4000万美元E轮融资。本轮融资后，公司最新一轮融资估值为10亿美元。本轮参投方包括8VC、JIC Venture Growth Investments、Echo Capital等多个知名机构。值得注意的是，Peter Thiel旗下的Thiel Capital、Founders Fund，以及...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2026-04-16/doc-inhusviy2842117.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞、赛诺菲押注！AI制药估值10亿美元，22款药物进入临床！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-16 18:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/roll/2026-04-16/doc-inhusviy2842117.shtml><strong>智药局</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AI制药再迎重磅融资！近日，美国波士顿AI制药公司Alloy Therapeutics宣布完成4000万美元E轮融资。本轮融资后，公司最新一轮融资估值为10亿美元。本轮参投方包括8VC、JIC Venture Growth Investments、Echo Capital等多个知名机构。值得注意的是，Peter Thiel旗下的Thiel Capital、Founders Fund，以及...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2026-04-16/doc-inhusviy2842117.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://finance.sina.com.cn/roll/2026-04-16/doc-inhusviy2842117.shtml","article_id":"2627291839","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627291839","pubTimestamp":1776333780,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"AI制药再迎重磅融资！近日，美国波士顿AI制药公司Alloy Therapeutics宣布完成4000万美元E轮融资。本轮融资后，公司最新一轮融资估值为10亿美元。截至目前，Alloy已与200多家合作伙伴建立合作。其中22个已进入临床开发阶段，2个处于3期临床。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4581":"高盛持仓","SG9999002232.USD":"Allianz Global High Payout USD","BK4599":"减肥药","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","BK4534":"瑞士信贷持仓","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4592":"伊斯兰概念","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","SNY":"赛诺菲安万特","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK4588":"碎股","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","SG9999001176.USD":"United Global Healthcare Acc USD","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4007":"制药","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK1191":"制药"},"translate_title":"Pfizer, Sanofi Bets! AI pharmaceuticals are valued at $1 billion, and 22 drugs enter the clinic!","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1.88,"SNY":1.86},"content_text":"AI制药再迎重磅融资！近日，美国波士顿AI制药公司Alloy Therapeutics宣布完成4000万美元E轮融资。本轮融资后，公司最新一轮融资估值为10亿美元。本轮参投方包括8VC、JIC Venture Growth Investments、Echo Capital等多个知名机构。值得注意的是，Peter Thiel旗下的Thiel Capital、Founders Fund，以及Mubadala Capital、Alexandria Venture Investments等老股东均选择跟投。本轮资金将重点用于：升级 AI/ML 药物发现引擎与数据层，强化人工智能和机器学习能力，构建连接整个开发流程的数据基础设施深化抗体、基因药、细胞疗法三大核心平台扩大临床前 & 临床开发服务能力Alloy成立于2017年，创始人Errik Anderson在生物技术行业拥有多年经验，曾参与多家成功的初创企业，包括Adimab， LLC. Arsanis和Alloy Therapeutics等。公司最初专注于抗体发现，但后来扩展至涵盖双特异性抗体，到基因药物、细胞疗法等领域。如今，结合AI驱动的模型、湿实验室和真实世界数据，Alloy正将自己定位为一个全方位服务平台，能够加快进度并降低成本。创始人表示，公司正在致力于成为医药研发的基础设施。“Alloy正在构建连接全球生物制药行业发现、开发和数据的基础设施层。我们的协作模式让合作伙伴能够保持在前沿，而无需内部构建所有能力。”截至目前，Alloy已与200多家合作伙伴建立合作。这些合作产生了超过100个获得许可的治疗项目。其中22个已进入临床开发阶段，2个处于3期临床。近年，Alloy多笔重磅BD交易密集落地，合作伙伴包括赛诺菲、辉瑞、渤健等跨国医药巨头。4月6日，公司与渤健（Biogen）达成多靶点合作，基于ASO平台开发中枢神经系统疾病药物；2025年2月，Alloy宣布与辉瑞达成战略合作，共同开发一个特异且有效抗体的新平台；2025年1月，Alloy与赛诺菲达成合作，共同开发一种新型反义寡核苷酸（ASO）药物，该笔合作2750万美元，里程碑付款及分成为4亿美元。由此可见，这些合作体现了Alloy在抗体、双特异性抗体，到基因药物、细胞疗法的跨平台潜力。随着医药公司加速布局AI制药，Alloy的全球化布局正在提速。Alloy表示，其业务和合作伙伴跨越美国、日本、中东及其他新兴生物技术中心。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}